Gut bacteria and cancer treatment before surgery
Part of Cancer, Digestive system clinical trials.
This study looks at the bacteria in your gut to see if they can predict how well chemotherapy or radiation works before surgery for certain cancers. If you have pancreatic, stomach, colon, or esophageal cancer that has spread nearby (but not to distant organs), you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with pancreatic, gastric, colorectal, or esophageal cancer (confirmed by biopsy).
- Your cancer is borderline resectable or locally advanced, and you are scheduled to receive chemotherapy or radiation before surgery.
- Your blood counts and liver/kidney function are within acceptable ranges (your doctor can confirm this).
- You haven't taken certain medications (like antibiotics, steroids, or proton pump inhibitors) for a week or more in the last 3 months.
- You haven't had major changes in your bowel habits or diet in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your gut bacteria might affect a treatment for lung cancer that combines chemotherapy and immunotherapy before surgery. It aims to see if certain bacteria can help the treatment work better.
This study looks at how the bacteria in your gut relate to your nutritional health while you receive chemotherapy for digestive cancer. By collecting stool and saliva samples, researchers hope to find new ways to support your nutrition during treatment.
This study looks at how bacteria in the gut and tumor affect breast cancer in women having surgery. The goal is to learn more about the cancer to improve treatment in the future.
This study looks at gut bacteria in people with colorectal cancer that has spread (metastatic). It aims to find patterns in the bacteria that may help doctors choose better treatments.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This trial tests whether the bacteria in your gut (microbiome) can affect how well immunotherapy works for lung cancer that can be surgically removed. You may receive immunotherapy or chemotherapy before surgery to shrink the tumor.
Hear when a new Digestive System Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.